ArticleScientific reports2026
Fungal-mediated green synthesis of ZnO-MnO nanocomposites with antimicrobial and anticancer properties.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synergistic antimicrobial and antibiofilm effects of mycosynthesized MnO-MgO bimetallic nanoparticles against drug-resistant pathogens.BMC microbiology · 2026Article
- Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The urgent need for sustainable therapeutic nanomaterials has driven interest in green synthesis routes. In this study, zinc oxide-manganese oxide nanocomposites were mycosynthesized by employing the fungal extracellular filtrate of Aspergillus terreus. Characterization based on different spectroscopical analysis confirmed their crystalline structure, associated functional groups, and nanoscale morphology. The obtained composites showed nanoscales with average particle sizes of 75 nm and 99 nm as determined by TEM and DLS analysis, respectively. Additionally, microbiological assays revealed their strong growth-ceasing activity against Escherichia coli and Bacillus subtilis strains. Also, the time-kill assessment demonstrated rapid bacterial reduction at higher nanocomposite doses. Cytotoxicity studies indicated good safety in the case of WI-38 normal cells, potent anticancer activity against the MCF-7 tumor cell line, and a respectable selectivity index approximately 3.4 for the tested cancerous cell line. These findings highlight fungal-mediated biosynthesis as an eco-friendly route for producing zinc oxide-manganese oxide nanocomposites with respected spectrum antimicrobial activity and anticancer potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.